Mar 23
NVZMF · NOVOZYMES AS
Market Cap
$31.02B
Shares
466.19M
Volume · Nov 11
132
Avg daily vol (3M)
710
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$66.54
Open$66.54
Day$66.54–66.54
52W close$52.10–71.12
Avg vol 30d795
Short int902K · 0.2% of shares · 999+d
Short vol78%
Last earningsAug 19, 2026
DataJan 2020–Nov 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
1.0%
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+7.3%
Trailing year
Short interest
0.2%
Latest settlement · 999+ days to cover
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.72
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+7%
above
Price vs 50-day avg
−1%
below
RSI (14)
47
neutral
MACD trend
Negative
52-week position
76%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+3%
trailing
6-month return
+11%
trailing
YTD return
+7%
this year
Relative strength
+9%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $67 › 200d $62 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.19% of shares out · ▼ -9.7% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
40
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
49%
annualized · 1-yr
Max drawdown
−27%
past year
ATR
2.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+7%
Bullish
Price vs 50-day avg
−1%
Neutral
RSI (14)
47
Neutral
MACD trend
Negative
Bearish
52-week position
76%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $67 › 200d $62 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.19% of shares out · ▼ -9.7% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $52
Now $67 · 76%
Range high $71
vs 200-day avg +7%
vs 50-day avg -1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NVZMF
this stock
NOVOZYMES AS
|
$31.02B | +6.5% | — | — | 0.2% |
|
LIN
Linde PLC
|
$239.87B | +22.5% | +3.0% | 34.7 | 1.4% |
|
AIQUF
L Air Liquide SA
|
$135.48B | +13.1% | — | — | 0.0% |
|
ECL
Ecolab Inc.
|
$85.38B | +16.0% | +2.2% | 41.4 | 1.5% |
|
SHW
Sherwin Williams Co
|
$84.89B | +8.4% | +2.1% | 32.3 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NVZMF | -3.2% | +2.7% | +10.8% | -3.1% | +6.5% |
| SPY | -0.9% | -1.3% | +2.3% | +0.5% | +11.4% |
| vs SPY | -2.3% | +4.0% | +8.5% | -3.7% | -4.9% |
Capital returns
Latest dividend
$0.661
/ share · ex Mar 24, 2026
Paid (TTM)
$0.661
/ share · 1 payout
Dividend yield (TTM, derived)
— · history filling in
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.